Thus, the current study provides novel insights into the molecular mechanism underlying the tight regulation of neutrophil attractant chemokine CXCL5 in the pathogenesis of NTHi-induced OM and also demonstrates the potential of curcumin as a novel therapeutic for treating OM (Fig. 8). The gene discussed is CXCL5; the disease is ocular melanoma.